Our Products

MiniTC™ – ‘Lab-in-your-hand’

FDA cleared, disposable, hand-held medical device for isolation of cell-enriched fat grafts (microfat) at the point-of-care.

Mini-Stem System™

CE Mark pending, disposable, portable medical device for isolation of adipose tissue derived stromal vascular fraction (SVF) at the point-of-care.

Pipeline stem cell therapeutic product (JTL-T-01)

Adipose tissue derived stem cell therapeutic product for Osteoarthritis.

MiniTC™ – Lab-in-your-hand

MiniTC™ is an FDA-cleared portable medical device for isolation of cell-enriched fat grafts (microfat) at the point-of-care. It is a patented, disposable, closed loop medical device that can be used for processing of lipoaspirate (fat) in any clinic setting, with no change in infrastructure. The end-product is finely washed injectable microfat which can be used for autologous implant alone or in conjunction with biocompatible carriers. The device can be used in a broad range of therapeutic areas, such as medical aesthetics, plastic and reconstructive surgeries, orthopedics and wound care.

 

Features:

  • FDA cleared, patented, disposable, closed loop medical device that can be used in various clinical settings

  • Enables point-of-care fat tissue processing to isolate cell enriched fat grafts (microfat)

Advantages:

  • No capital costs

  • Half the cost compared to leading competitors in the US and Europe

  • Superior performance

  • Easy to use and less cumbersome

  • Can also be used as a platform for combination therapies and clinical research

Microfat

Microfat is your own processed and filtered fat, which is rich in regenerative cells. Microfat preserves the integrity of fat tissue and the stromal (stem) cells within its natural niche which helps in the reconstruction, regeneration and healing of tissues. Microfat can then be applied or injected to areas of injury, inflammation or for aesthetic contouring.

Mini-Stem System™

Mini-Stem System™ system is a CE-mark pending medical device for isolation of fat-derived stromal vascular fraction (SVF) at the point-of-care. It is a patented, disposable, closed loop medical device that can be used for processing of lipoaspirate (fat) in any clinic setting, with no change in infrastructure. The end-product is an injectable stem cell fraction (SVF) which can be used for autologous therapy alone or in conjunction with biocompatible carriers. The device can be used in a broad range of therapeutic areas, such as medical aesthetics, plastic & reconstructive surgeries, orthopedics and wound care.

 

Features:

  • CE-mark pending, patented, disposable, closed loop medical device that can be used in various clinical settings

  • Enables point-of-care fat tissue processing to stem cell fraction (SVF).

Advantages:

  • No major capital costs

  • Half the price to leading competitors

  • Superior performance

  • Easy to use and less cumbersome

  • Can also be used as a platform for combination therapies and clinical research

Stromal Vascular Fraction (SVF)

SVF is a cellular product rich in your own fat-derived stem cells that have been shown to possess powerful anti-inflammatory and immunomodulatory functions. SVF, when injected, helps in the reconstruction, regeneration and healing of tissues.

Pipeline Stem Cell Therapeutic Product (JTL-T-01)

Based on our platform and technology, Jointechlabs is developing therapies for unmet medical needs. Our first therapeutic in clinical development JTL-T-01 is a proprietary injectable stem cell scaffold as a biologic therapy for osteoarthritis, for approval under the FDA’s fast-track program. JTL-T-01 has been designed as an autologous point-of-care therapy enabling the patient’s own stem cells to be locally injected into the affected joints. A portion of the pre-clinical study for JTL-T-01 is funded by the National Institutes of Health’s small business grant in collaboration with Rush University, Chicago.

Application

MiniTC™ (USA) and Mini-Stem System™ (EU and other countries) have applications in medical aesthetics, plastic and reconstructive surgery, orthopedics and wound healing among others. 

Restores fullness and shape; adds volume; decreases skin sag; erases stretch marks.

Rejuvenation of face; improves skin texture, wrinkles, fine lines and acne scars; adds volume.

Improves blood circulation to chronic wounds; decreases inflammation and pain; promotes faster healing and regeneration

Reduces pain; decreases inflammation; helps repair cartilage and soft tissue injuries; improves healing and prompts return to active lifestyle.

Procedure

MiniTC™

MiniTC™ offers a simplified protocol of just two centrifugation steps for obtaining injectable microfat in about 20 minutes. Step one eliminates the blood and anesthetic contaminants, and step two allows breaking of dense fat into microfat where regenerative cells are preserved. Injectable microfat is then collected by connecting the syringe to the luer on top of the device.
(Please follow the Instructions for use when using MiniTC™). 

Mini-Stem System™

Mini-Stem System™  replicates the multi-step laboratory process of isolating stromal vascular fraction (SVF) from fat, but within the portable device in a closed-loop by introducing and collecting the materials through particular luer ports on the device. The main steps of the Mini-Stem System protocol, which are tissue washing, tissue enzymatic digestion and filtration of the digested fraction, are executed within the device itself.
(Please follow the instructions for use when using Mini-Stem System™)

JTL-T-01 Pipeline Therapeutic

JTL-T-01 Therapy is a pipeline therapeutic product under clinical development which combines a unique method of stromal vascular fraction (SVF) extraction from fat and its embedment into injectable scaffold. JTL-T-01 has been designed as an autologous point-of-care therapy for osteoarthritis useful for mitigation of pain, inflammation and cartilage deterioration.

Accessory Equipment

Biospins Centrifuge

Multipurpose digital centrifuge recommended for MiniTC™ and Mini-Stem System™ protocols. It can run 99 other programs as needed.

Biospins Shaker

Multipurpose digital temperature-controlled shaker recommended for Mini-Stem System™ protocol.

Liposuction Cannula Kit

Convenient sterile, cost effective kit for minimally-invasive liposuction at the point-of-care.

Tech & Innovation

Jointechlabs designed its innovative devices to harness the natural healing powers of the body. We continue to pioneer innovation by using the MiniTC™ and Mini-Stem System™ devices as platform to develop novel products. 

 

Tissue 3D printing 

We are working on tissue 3D printing based on a combination of our devices with existing portable 3D bioprinting device, and proprietary scaffold hydrogels which will provide unique opportunity for development of breakthrough therapies for unmet medical needs. The platform and the method of embedment of the cellular product into injectable and printable biologic product are protected by broad portfolio of issued patents, pending patents and PCTs.

 

Therapy Development through partnerships

Using our devices as a platform, we are developing therapies with biotech/government partners for different clinical indications as below;

  • Fibralign’s BioBridge collagen matrix scaffold in combination with adipose stem cells derived from Mini-Stem System™ for treatment of lymphedema, vascular diseases.
  • Procore Bio’s hydrogel scaffold in combination with adipose stem cells derived from Mini-Stem System™ for orthopedic applications. 
  • NIH sponsored small business grant (SBIR) for development of effective autologous point-of-care (POC) cell therapy for osteoarthritis.
  • Wound healing therapy applications using 3D printed biomaterials. 

Scientific and Industry Partnership

Strategic Partnership

Distributors

Team

Testimonial

Frequently Asked Questions

MiniTC™ is a disposable, closed loop medical device that can be used in the clinic setting, with no change in infrastructure, eliminating the need for manual processing of fat tissue. Also, the device is less costly, cumbersome and labor intensive compared to what currently exists. 

Yes, with MiniTC™, manual processing of fat tissue in the lab is eliminated, thus making it more standardized and applicable in clinic settings.

MiniTC™ is intended for use in the following specialties when the transfer of harvested adipose tissue is desired: orthopedics, arthroscopic surgery, plastic and reconstructive surgery (when aesthetic body contouring is desired), neurosurgery, gastrointestinal and affiliated organ surgery, urological surgery, general surgery, gynecological surgery, thoracic surgery and laparoscopic surgery.

For the use of MiniTC™, Jointechlabs plans to focus on reaching healthcare practitioners and physicians in a variety of specialties, including medical aesthetics, plastic and reconstructive surgery, orthopedics, internal medicine (e.g., primary care physicians who handle aesthetics or orthopedic procedures) and wound healing.

MiniTC™ can be purchased from authorized distributors in your territory. A list of distributors is available on the website . If your territory is not currently assigned to a distributor, you can purchase MiniTC directly from Jointechlabs by reaching us via our contact page

There are several ways to receive training of MiniTC™. In some cases training can be arranged in-person. Otherwise, Jointechlabs offers an online webinar in addition to ‘how-to-use’ training and 3D animation videos, along with instructions-for-use details, available on the website

Blog

Regenerative Medicine: The Field Has Come a Long Way and Now is Having its Moment

Jointechlabs Launches MiniTC for Point-of-Care Fat Tissue Processing The scientific community has regarded regeneration as a topic of interest for thousands of years.

FDA Clears Jointechlabs’ MiniTC for Point-of-Care Fat Tissue Processing and its Broad Range of Applications

Jointechlabs – a leader in point-of-care regenerative medicine therapies – today announced that the U.S. Food and Drug Administration (FDA) cleared the […]

Combining freshly isolated adipose-derived cells with Regenogel-OSP

Nathan Katz, MSc, PhD, Jointechlabs, Inc., USA Avner Yayun, MD, PhD, Procore Biomed, Israel Procore Biomed has developed a hyaluronic-acid – plasma cross-linked hydrogel “RegenoGel” ..

Contact Us

Address

 108 South Wynstone Park drive, Suite 114, North Barrington IL 60010

 

Monday to Saturday:

9am-6pm

 

Phone :

800-217-0491

 

Email:

info@jointechlabs.com